Department of Biomedical and Pharmaceutical Sciences, Chapman University School of Pharmacy, Irvine, California, United States.
Department of Pharmaceutical Sciences, Northeastern University School of Pharmacy, Boston, Massachusetts, United States.
Am J Physiol Cell Physiol. 2023 Mar 1;324(3):C658-C664. doi: 10.1152/ajpcell.00584.2022. Epub 2023 Jan 30.
Small-conductance Ca-activated potassium channels subtype 2 (K2.2, also called SK2) are operated exclusively by a Ca-calmodulin gating mechanism. Heterozygous genetic mutations of K2.2 channels have been associated with autosomal dominant neurodevelopmental disorders including cerebellar ataxia and tremor in humans and rodents. Taking advantage of these pathogenic mutations, we performed structure-function studies of the rat K2.2 channel. No measurable current was detected from HEK293 cells heterologously expressing these pathogenic K2.2 mutants. When coexpressed with the K2.2_WT channel, mutations of the pore-lining amino acid residues (I360M, Y362C, G363S, and I389V) and two proline substitutions (L174P and L433P) dominant negatively suppressed and completely abolished the activity of the coexpressed K2.2_WT channel. Coexpression of the K2.2_I289N and the K2.2_WT channels reduced the apparent Ca sensitivity compared with the K2.2_WT channel, which was rescued by a K2.2 positive modulator.
小电导钙激活钾通道亚基 2(K2.2,也称为 SK2)仅由 Ca-钙调蛋白门控机制操作。K2.2 通道的杂合遗传突变与常染色体显性神经发育障碍有关,包括人类和啮齿动物的小脑共济失调和震颤。利用这些致病突变,我们对大鼠 K2.2 通道进行了结构功能研究。从异源表达这些致病 K2.2 突变体的 HEK293 细胞中未检测到可测量的电流。当与 K2.2_WT 通道共表达时,孔衬氨基酸残基(I360M、Y362C、G363S 和 I389V)和两个脯氨酸取代(L174P 和 L433P)的突变显性负性抑制并完全消除了共表达的 K2.2_WT 通道的活性。与 K2.2_WT 通道相比,K2.2_I289N 和 K2.2_WT 通道的共表达降低了明显的 Ca 敏感性,而 K2.2 阳性调节剂可挽救这种敏感性。